FAK inhibitors in Cancer, a patent review.

about

Endogenous Control Mechanisms of FAK and PYK2 and Their Relevance to Cancer Development.

P2860

Q54976490-8BB29D78-D83A-4B42-9FA5-9F16CE3C9467

P2860

FAK inhibitors in Cancer, a patent review.

Item

http://www.wikidata.org/entity/Q47797785

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

FAK inhibitors in Cancer, a patent review.

@en

FAK inhibitors in Cancer, a patent review.

@nl

type

Item

label

FAK inhibitors in Cancer, a patent review.

@en

FAK inhibitors in Cancer, a patent review.

@nl

prefLabel

FAK inhibitors in Cancer, a patent review.

@en

FAK inhibitors in Cancer, a patent review.

@nl

P1476

FAK inhibitors in Cancer, a patent review.

@en

P2093

Ai-Qin Jiang

http://www.w3.org/2001/XMLSchema#string

Hai-Liang Zhu

http://www.w3.org/2001/XMLSchema#string

Peng-Cheng Lv

http://www.w3.org/2001/XMLSchema#string

Wei-Ming Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Cell mechanics and the cytoskeleton

Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271

Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): structure-activity relationships and strategies for the elimination of reactive metabolite formation

Structural Characterization of Proline-rich Tyrosine Kinase 2 (PYK2) Reveals a Unique (DFG-out) Conformation and Enables Inhibitor Design

Sulfoximine-substituted trifluoromethylpyrimidine analogs as inhibitors of proline-rich tyrosine kinase 2 (PYK2) show reduced hERG activity

Discovery and characterization of novel allosteric FAK inhibitors

Structure-based discovery of cellular-active allosteric inhibitors of FAK

Signaling through focal adhesion kinase

Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis.

Focal adhesion kinase: the first ten years

P304

139-145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1080/13543776.2018.1414183

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29210300

http://www.w3.org/2001/XMLSchema#string

FAK inhibitors in Cancer, a patent review.

about

P2860

P2860

FAK inhibitors in Cancer, a patent review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698